Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into an initiative to create a "virtual cell" that researchers can use to combat disease, as reported earlier by Reuters. The project is led by Biohub, a nonprofit biomedical research organization founded by Mark Zuckerberg and his wife, Priscilla Chan. It comes as part of a $1. 8 billion "Virtual Biology" initiative to build AI datasets that could allow researchers to "ask, predict, and answer biological questions digitally. " Founded in 2016, Biohub aims to prevent and cure diseases through the creation of a "high-accuracy predictive mode … Read the full story at The Verge.
Oct 7, 2026 → Oct 9, 2026
Meta had delayed releasing Muse, its A. I. agent app, for months over safety concerns. Then new competition forced Mr. Zuckerberg’s hand.
Read original at NYT →4 updates from 4 sources over 2 days.
Meta had delayed releasing Muse, its A. I. agent app, for months over safety concerns. Then new competition forced Mr. Zuckerberg’s hand.
Read original at NYT →A new film paints the Meta founder as a villain. But the tech firm seems immune to bad publicity, writes our North America tech correspondent.
Read original at BBC →Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc. ’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the…
Read original at Bloomberg →Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into an initiative to create a "virtual cell" that researchers can use to combat disease, as reported earlier by…
Read original at The Verge →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
Meta had delayed releasing Muse, its A. I. agent app, for months over safety concerns. Then new competition forced Mr. Zuckerberg’s hand.
View source →A new film paints the Meta founder as a villain. But the tech firm seems immune to bad publicity, writes our North America tech correspondent.
View source →Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc. ’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.
View source →Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into an initiative to create a "virtual cell" that researchers can use to combat disease, as reported earlier by Reuters. The project…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
The AI firm instead claims the researchers were fired for mishandling sensitive information.
Several configurations of the Apple Watch Series 12 are $50 off for the first time for the remainder of Amazon’s Prime Big Deal Days. This includes both sizes (42mm and 46mm) of…
Aaron Sorkin’s sequel to The Social Network attempts to shame a ruling class that has proved itself shameless.
Display ads, what a concept.
Meredith Whittaker says the tech has been misunderstood, in an exclusive interview with BBC Global Women.
China’s tech hardware shares are rapidly losing value after bumper gains earlier in the year, as growing doubts over the global AI trade make those high-valuation names…
